These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 39066205)

  • 1. Dynamic Changes in Viral Loads during Co-Infection with a Recombinant Turkey Herpesvirus Vector Vaccine and Very Virulent Marek's Disease Virus In Vivo.
    Ding T; Xiong M; Xu Y; Pu X; Wang QS; Xu MR; Shao HX; Qian K; Dang HB; Qin AJ
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turkey herpesvirus with an insertion in the UL3-4 region displays an appropriate balance between growth activity and antibody-eliciting capacity and is suitable for the establishment of a recombinant vaccine.
    Andoh K; Yamazaki K; Honda Y; Honda T
    Arch Virol; 2017 Apr; 162(4):931-941. PubMed ID: 27942974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
    Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
    Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Recombinant Marek's Disease Virus Vaccine 301B/1 Expressing Membrane-Anchored Chicken Interleukin-15.
    Kim T; Hearn C; Heidari M
    Avian Dis; 2024 Jun; 68(2):117-128. PubMed ID: 38885053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ influences immunity elicited by vaccines against very virulent Marek's disease virus.
    Haq K; Elawadli I; Parvizi P; Mallick AI; Behboudi S; Sharif S
    Antiviral Res; 2011 Jun; 90(3):218-26. PubMed ID: 21501630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of diluting Marek's disease vaccines on the outcomes of Marek's disease virus infection when challenged with highly virulent Marek's disease viruses.
    Gimeno IM; Cortes AL; Montiel ER; Lemiere S; Pandiri AK
    Avian Dis; 2011 Jun; 55(2):263-72. PubMed ID: 21793444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a mechanistic understanding of the synergistic response induced by bivalent Marek's disease vaccines to prevent lymphomas.
    Umthong S; Dunn JR; Cheng HH
    Vaccine; 2019 Oct; 37(43):6397-6404. PubMed ID: 31515142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
    Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR
    Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of viral telomeric repeat sequences on herpesvirus vector vaccine integration and persistence.
    Denesvre C; You Y; Rémy S; Vychodil T; Courvoisier K; Penzes Z; Bertzbach LD; Kheimar A; Kaufer BB
    PLoS Pathog; 2024 May; 20(5):e1012261. PubMed ID: 38805555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between levels of very virulent MDV in poultry dust and in feather tips from vaccinated chickens.
    Baigent SJ; Kgosana LB; Gamawa AA; Smith LP; Read AF; Nair VK
    Avian Dis; 2013 Jun; 57(2 Suppl):440-7. PubMed ID: 23901759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-Infection with Marek's Disease Virus and Reticuloendotheliosis Virus Increases Illness Severity and Reduces Marek's Disease Vaccine Efficacy.
    Sun GR; Zhang YP; Zhou LY; Lv HC; Zhang F; Li K; Gao YL; Qi XL; Cui HY; Wang YQ; Gao L; Pan Q; Wang XM; Liu CJ
    Viruses; 2017 Jun; 9(6):. PubMed ID: 28635675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A toll-like receptor 3 ligand enhances protective effects of vaccination against Marek's disease virus and hinders tumor development in chickens.
    Parvizi P; Mallick AI; Haq K; Haghighi HR; Orouji S; Thanthrige-Don N; St Paul M; Brisbin JT; Read LR; Behboudi S; Sharif S
    Viral Immunol; 2012 Oct; 25(5):394-401. PubMed ID: 22857262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection provided by Rispens CVI988 vaccine against Marek's disease virus isolates of different pathotypes and early prediction of vaccine take and MD outcome.
    Ralapanawe S; Walkden-Brown SW; Renz KG; Islam AF
    Avian Pathol; 2016; 45(1):26-37. PubMed ID: 26503904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of Efficacy and Replication of Recombinant Vector Vaccines by Using Turkey Herpesvirus Combined with Other Marek's Disease Vaccines.
    Gimeno IM; Cortes AL; Reilley A; Barbosa T; Alvarado I; Koopman R; Martinez A
    Avian Dis; 2019 Jun; 63(2):335-341. PubMed ID: 31251535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-induced host responses against very virulent Marek's disease virus infection in the lungs of chickens.
    Haq K; Abdul-Careem MF; Shanmuganthan S; Thanthrige-Don N; Read LR; Sharif S
    Vaccine; 2010 Aug; 28(34):5565-72. PubMed ID: 20600510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
    Buscaglia C; Nervi P; Risso M
    Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Load of challenge Marek's disease virus DNA in blood as a criterion for early diagnosis of Marek's disease tumors.
    Gimeno IM; Cortes AL; Silva RF
    Avian Dis; 2008 Jun; 52(2):203-8. PubMed ID: 18646447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Various HVT Vaccines (Conventional and Recombinant) Against Marek's Disease in Broiler Chickens: Effect of Dose and Age of Vaccination.
    Gimeno IM; Cortes AL; Faiz N; Villalobos T; Badillo H; Barbosa T
    Avian Dis; 2016 Sep; 60(3):662-8. PubMed ID: 27610727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.
    Liu S; Sun W; Chu J; Huang X; Wu Z; Yan M; Zhang Q; Zhao P; Igietseme JU; Black CM; He C; Li Y
    PLoS One; 2015; 10(4):e0124992. PubMed ID: 25893439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.